Q&A from the "What is Learning?" video series with Dr. Jonas Hauser
In this short podcast Dr. Hauser answers four questions focused on the fascinating world of HMOs and their potential role in infant cognition. (listening time 14minutes).”
During this podcast, Dr. Hauser will discuss the following questions:
- Evidence suggests that HMO 2’-FL is associated with cognition in infants. What is the consequence for infants who do not have high levels of 2’-FL in their milk?
- What is the mechanism behind 2’-FL specifically being associated with cognitive development?
- Pre-clinical evidence suggests that the vagus nerve may play a role in allowing HMOs to support brain functions. What do we know about vagus nerve development in infants?
- Will different HMOs affect different brain areas or functions?
Other content that you might be interested in:
[Video] HMOs and Cognition - Dr. Jonas Hauser
WYE-EM-060-MAY-22
If you liked this post you may also like

Factors influencing brain development in early life
Factors influencing brain development in early life

AI in healthcare - friend or foe?
AI in healthcare - friend or foe?

“The Learning Lead” - Volume 1 (2022)
“The Learning Lead” - Volume 1 (2022)

[Science Update] Relationship between metabolites modulated by HMOs and reduced risk of LRTIs
[Science Update] Relationship between metabolites modulated by HMOs and reduced risk of LRTIs